You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Rapport Therapeutics Inc. - Company Information, Overview, History and Profile

What does Rapport Therapeutics Inc. do?

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Rapport Therapeutics Inc. Management structure

All Gross Remunerations are in USD
Mr. Troy A. Ignelzi
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Abraham N. Ceesay, M.B.A.
Chief Executive Officer and Director
-
2024
Gross Remuneration
Year

Rapport Therapeutics Inc. Board of directors

All Gross Remunerations are in USD
Dr. John M. Maraganore,PhD
Director
-
2024
Gross Remuneration
Year
Mr. Robert J. Perez
Director
-
2024
Gross Remuneration
Year
Dr. Steven M. Paul, M.D.
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. James I. Healy, M.D.,PhD
Director
-
2024
Gross Remuneration
Year
Mr. Paul M. Silva
Director
-
2024
Gross Remuneration
Year
Dr. Reid M. Huber, PhD
Director
-
2024
Gross Remuneration
Year